1998
DOI: 10.1111/j.1469-8749.1998.tb15354.x
|View full text |Cite
|
Sign up to set email alerts
|

Precocious puberty in children with myelomeningocele: treatment with gonadotropin‐releasing hormone analogues

Abstract: In patients with myelomeningocele (MMC), growth is influenced by a large number of growth‐retarding factors due to the neurological defect. Moreover, endocrine disorders have been found to contribute to short stature in MMC patients. Central precocious puberty (CPP) is a common problem. Due to growth disturbances and difficulties in obtaining standardized measurements, MMC patients have been excluded from gonadotropin‐releasing hormone (GnRH) analogue studies in the past. We report on eight patients (six femal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(16 citation statements)
references
References 23 publications
0
16
0
Order By: Relevance
“…Paradoxically, four of the 37 patients exhibited BMD above age-and-sex-matched mean, some as high as 2.4 SD above the mean (Table 3). The number of patients exhibiting BMD at or above the mean is too small for meaningful analysis but may relate to obesity [8] or precocious puberty [15]. The majority of subjects demonstrated Z-scores lower than age-and-sexmatched means (Table 2).…”
Section: Discussionmentioning
confidence: 99%
“…Paradoxically, four of the 37 patients exhibited BMD above age-and-sex-matched mean, some as high as 2.4 SD above the mean (Table 3). The number of patients exhibiting BMD at or above the mean is too small for meaningful analysis but may relate to obesity [8] or precocious puberty [15]. The majority of subjects demonstrated Z-scores lower than age-and-sexmatched means (Table 2).…”
Section: Discussionmentioning
confidence: 99%
“…However, with respect to various disease-related complications in patients with MMC, long-term efficacy of GH in MMC patients might be influenced by consequences of the spinal lesion such as immobility, symptomatic tethered spinal cord, scoliosis or contractures. In addition, other endocrine disorders, most importantly precocious puberty or advanced pubertal development with rapid bone age acceleration, might interfere with GH effects [23,24].…”
Section: Discussionmentioning
confidence: 99%
“…The increasing divergence after age 8 years is due to the added effect of scoliosis (10,12) during this time of rapid growth (15) associated with the beginning of puberty (32). The difference in the widening of the discrepancy between height and arm span is less evident in the intermediate paralyzed group (LL2) (Tables 3-5, Figure 2) and less so in the least paralyzed (LL3) (Tables 3-5, Figure 3) because of less severe paralysis (1) and a lower frequency of scoliosis (12).…”
Section: Discussionmentioning
confidence: 99%